NEW YORK (GenomeWeb News) – Following the announcement earlier this week that Thermo Fisher Scientific plans to acquire Life Technologies for $13.6 billion, a number of investment analysts changed their ratings for both companies.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.
Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."
Ivan Oransky discusses the need for reproducibility research at The Conversation.
The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.